RARE TUMORS S1609
Study #S1609DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors
Back To Clinical Trials NCI Database Entry
DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors
Back To Clinical Trials NCI Database Entry